Advent Capital Management AMPHASTAR PHARMACEUTICAL Transaction History
Advent Capital Management
- $195 Million
- Q2 2025
Number of Shares
3,209,000
Previous 3,032,000
5.84%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%